[1]
“Clinical Outcomes, Barriers and Facilitators to Hydroxyurea Use for Sickle Cell Anemia: A Mixed Method Study at Muhimbili National Hospital, Tanzania”, TMJ, vol. 35, no. 1, pp. 1–18, Mar. 2024, doi: 10.4314/jhrpgv89.